Education
About Us
Working with TipRanks
Follow Us
Luye Pharma Group Ltd. (HK:2186)
:2186
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 6.06B | ¥ 6.14B | ¥ 5.98B | ¥ 5.20B | ¥ 5.54B |
| Gross Profit | ¥ 4.04B | ¥ 4.20B | ¥ 4.14B | ¥ 3.40B | ¥ 3.99B |
| Operating Income | ¥ 1.15B | ¥ 917.88M | ¥ 880.62M | ¥ 437.96M | ¥ 1.02B |
| EBITDA | ¥ 1.79B | ¥ 2.08B | ¥ 1.81B | ¥ 906.88M | ¥ 1.88B |
| Net Income | ¥ 471.89M | ¥ 532.61M | ¥ 604.81M | ¥ -134.39M | ¥ 706.59M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 6.50B | ¥ 6.11B | ¥ 5.54B | ¥ 5.51B | ¥ 5.41B |
| Total Assets | ¥ 29.61B | ¥ 25.49B | ¥ 24.25B | ¥ 22.58B | ¥ 20.63B |
| Total Debt | ¥ 10.32B | ¥ 8.42B | ¥ 9.10B | ¥ 9.49B | ¥ 9.98B |
| Net Debt | ¥ 5.38B | ¥ 5.18B | ¥ 6.78B | ¥ 7.05B | ¥ 6.12B |
| Total Liabilities | ¥ 13.86B | ¥ 11.96B | ¥ 13.21B | ¥ 13.47B | ¥ 12.53B |
| Stockholders' Equity | ¥ 14.15B | ¥ 12.53B | ¥ 10.18B | ¥ 8.49B | ¥ 7.89B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -1.54B | ¥ 430.23M | ¥ 490.14M | ¥ -1.36B | ¥ -486.43M |
| Operating Cash Flow | ¥ 167.76M | ¥ 1.60B | ¥ 1.65B | ¥ 182.37M | ¥ 1.03B |
| Investing Cash Flow | ¥ -1.47B | ¥ -1.42B | ¥ -1.66B | ¥ -3.44B | ¥ 138.20M |
| Financing Cash Flow | ¥ 2.96B | ¥ 841.60M | ¥ 54.15M | ¥ 1.88B | ¥ 253.98M |